Overcoming a roadblock in the study of electrical cell signaling, scientists have developed biosensor arrays capable of monitoring electrical communication between cells in 3D tissue culture that model the complexity of organs (known as organoids). Such technologies may enable much needed research into the relationship between electrical signals and disease, promoting drug development and treatments for conditions such as arrhythmias (irregular heartbeat). Read more in Science Advances: https://

Cell Signaling Technology, Inc. on Reels

The CST Difference—in Their Words “[CST is] a company that has an ear to the ground. They're always paying attention to what is up-and-coming, and they're very willing to get involved during the development stages of new scientific ideas.” —Michael B Yaffe, PhD (Director, MIT Center for Precision Cancer Medicine) https://cst-science.com/me2g4n | Cell Signaling Technology, Inc.